Search results
MD Anderson Research Highlights: EHA 2024 Special | Newswise
Newswise· 7 days agoThe University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research, and prevention. Thes
Young cancer warrior still on "Team Victory" for Dallas Mavericks
CBS News· 6 days agoPreston Pipkins has a bedroom that does not require interpretation about who has his support in the...
StockNews.com Begins Coverage on Moleculin Biotech (NASDAQ:MBRX)
ETF DAILY NEWS· 7 days agoInvestment analysts at StockNews.com began coverage on shares of Moleculin Biotech (NASDAQ:MBRX – Get Free Report) in a note issued to investors on Thursday. The brokerage set a “sell” rating ...
Rigel Pharmaceuticals’ (RIGL) “Buy” Rating Reiterated at HC Wainwright
ETF DAILY NEWS· 2 days agoRigel Pharmaceuticals (NASDAQ:RIGL – Get Free Report)‘s stock had its “buy” rating reissued by stock analysts at HC Wainwright in a report released on Monday, Benzinga reports. StockNews.com ...
Actinium Pharmaceuticals (NYSEAMERICAN:ATNM) Earns Buy Rating from HC Wainwright
ETF DAILY NEWS· 2 days agoActinium Pharmaceuticals (NYSEAMERICAN:ATNM – Get Free Report)‘s stock had its “buy” rating reissued by equities researchers at HC Wainwright in a research report issued on Monday, Benzinga ...
Cullinan Therapeutics, Inc. (NASDAQ:CGEM) Sees Significant Growth in Short Interest
ETF DAILY NEWS· 2 days agoCullinan Therapeutics, Inc. (NASDAQ:CGEM – Get Free Report) saw a significant growth in short interest in the month of May. As of May 31st, there was short interest totalling 4,340,000 shares ...
American Trust Sells 187 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ)
ETF DAILY NEWS· 3 days agoAmerican Trust lowered its holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 10.3% in the 4th quarter, according to the company in its most recent filing with the Securities ...
MEI Pharma (NASDAQ:MEIP) Research Coverage Started at StockNews.com
ETF DAILY NEWS· 4 days agoResearch analysts at StockNews.com assumed coverage on shares of MEI Pharma (NASDAQ:MEIP – Get Free Report) in a note issued to investors on Sunday. The firm set a “buy” rating on the stock.
Traders Purchase Large Volume of Call Options on SELLAS Life Sciences Group (NASDAQ:SLS)
ETF DAILY NEWS· 5 days agoSELLAS Life Sciences Group, Inc. (NASDAQ:SLS – Get Free Report) was the recipient of some unusual options trading activity on Wednesday. Stock investors acquired 5,244 call options on the company ...
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Given Average Rating of “Moderate Buy” by Analysts
ETF DAILY NEWS· 3 days agoShares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Get Free Report) have received a consensus rating of “Moderate Buy” from the fourteen brokerages that are covering the stock, MarketBeat.com ...